XML 68 R57.htm IDEA: XBRL DOCUMENT v3.25.3
INTANGIBLE ASSETS AND GOODWILL - Narrative (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Goodwill [Line Items]          
Asset impairments $ 1,000,000 $ 0 $ 1,000,000 $ 6,000,000  
Finite-lived intangible assets 3,032,000,000   3,032,000,000   $ 3,753,000,000
Accumulated goodwill impairment charges $ 5,497,000,000   $ 5,497,000,000    
Vision Care, Pharmaceuticals and Surgical          
Goodwill [Line Items]          
Fair value of reporting value, greater than its carrying value 25.00%   25.00%    
Goodwill, impairment loss     $ 0    
Maximum | Vision Care, Pharmaceuticals and Surgical          
Goodwill [Line Items]          
Reporting unit, impairment test, long-term growth rate 3.00%   3.00%    
Reporting unit, impairment test, estimated cash flows, discount rate 11.50%   11.50%    
Minimum | Vision Care, Pharmaceuticals and Surgical          
Goodwill [Line Items]          
Reporting unit, impairment test, estimated cash flows, discount rate 10.00%   10.00%    
Xifaxan Branded Products          
Goodwill [Line Items]          
Finite-lived intangible assets $ 1,212,000,000   $ 1,212,000,000    
Finite lived intangible assets, useful life 27 months   27 months